DEF: Longeveron Seeks Stockholder Approval for Director Election and Incentive Plan Amendment at 2025 Annual Meeting

Longeveron Inc. is holding its 2025 Annual Meeting of Stockholders on June 13, 2025, to elect a director, approve an amendment to the 2021 Incentive Award Plan, and ratify the appointment of CBIZ CPAs P.C. as the independent auditor.

Summary

• Longeveron Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 13, 2025.
• Stockholders will vote on the election of one director to serve until the 2028 Annual Meeting.
• They will also vote on an amendment to the Longeveron 2021 Incentive Award Plan to increase the number of shares authorized by 4,000,000, bringing the total to 8,097,860 shares.
• Additionally, stockholders will ratify the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The record date for determining stockholders eligible to vote is April 21, 2025.
• Proxy materials were first mailed or made available to stockholders on or about April 28, 2025.
• The board recommends voting for the director nominee and for the proposals to amend the incentive award plan and ratify the auditor appointment.

Sentiment

Score: 7

Explanation: The document is primarily factual and procedural, with a neutral to slightly positive tone due to the emphasis on accessibility and good corporate governance practices.

Positives

• The virtual format of the Annual Meeting enhances accessibility for stockholders.
• The proposed amendment to the 2021 Incentive Award Plan aims to attract and retain key personnel.
• Ratification of the independent auditor supports corporate governance best practices.

Risks

• Failure to ratify the appointment of CBIZ CPAs P.C. would require the Audit Committee to reconsider the appointment.
• The potential for compensation arrangements to exceed deductibility limits under Section 162(m) of the Code is noted.

Future Outlook

The company is focused on attracting, retaining, and motivating key personnel through long-term incentive plans and aligning executive compensation with company performance and stockholder value.

Management Comments

• Dr. Joshua Hare, Chairman of the Board & Chief Science Officer, expresses pleasure in inviting stockholders to the 2025 Annual Meeting and highlights the enhanced accessibility provided by the virtual format.
• The Board believes that its current leadership structure provides appropriate Board leadership and engagement while deriving the benefits from having our CSO also serve as Chairman of the Board.

Industry Context

The document reflects standard corporate governance practices for publicly traded companies, including proxy solicitations, director elections, executive compensation disclosures, and auditor ratification. The use of a virtual annual meeting aligns with current trends in corporate governance to enhance accessibility and reduce costs.

Comparison to Industry Standards

• The executive compensation structure, including base salary, bonus, and equity awards, is typical for clinical-stage biotechnology companies.
• The director compensation program, including annual retainers and equity grants, is consistent with industry practices.
• The related party transaction disclosures are in line with SEC requirements and aim to provide transparency to investors.

Management Changes

Corporate Governance

Related Party Transactions

• The company has a consulting services agreement with Dr. Hare, the CSO, with an initial term of ten years and automatic renewals.
• The company is a licensee under an exclusive license agreement with JMHMD Holdings, LLC, an affiliate of Dr. Hare, for CD271+ cellular therapy technology.
• Dr. Hare, Mr. Rock Soffer, and Mr. Hashad participated in a public offering of Class A Common Stock and accompanying Common Warrants.

Stakeholder Impact

• Approval of the incentive award plan amendment could positively impact employees by providing additional equity-based compensation opportunities.
• Ratification of the independent auditor aims to enhance investor confidence in the company's financial reporting.
• The virtual annual meeting format is intended to improve accessibility for all stockholders.

Next Steps

• Stockholders are urged to vote their shares promptly by following the instructions provided in the Notice of Internet Availability of Proxy Materials or by returning a printed proxy card.
• The company will proceed with the Annual Meeting on June 13, 2025, and implement the outcomes of the stockholder votes.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Director Election, Incentive Award Plan, CBIZ CPAs P.C., Corporate Governance, Stockholders, Longeveron